Clinical trials · Seattle, WA
Recurrent Childhood Acute Myeloid Leukemia clinical trials in Seattle
We’re tracking 3 recruiting recurrent childhood acute myeloid leukemia studies with a site in or near Seattle — including Phase 1 studies, each written for real people, not researchers.
Recruiting studies near Seattle
- NCT06247787RecruitingPhase 1
Imetelstat plus chemo for relapsed leukemia in kids
This trial tests a new drug called imetelstat combined with two chemotherapy drugs (fludarabine and cytarabine) for children and teens with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or juvenile myelomonocytic leukemia (JMML) that has come back or not responded to treatment. The goal is to find the safest dose of imetelstat and see if it helps control the cancer.
Seattle, WashingtonAges 1–18 - NCT06609928RecruitingPhase 1
CAR T cell therapy for children with relapsed AML that has FOLR1
This trial tests a special immune cell treatment (CAR T cells) that target a protein called FOLR1 found on some AML cells. It is for children aged 6 or younger whose leukemia has come back or not responded to treatment.
Seattle, WashingtonAges Up to 6 years - NCT03326921RecruitingPhase 1
T cell treatment for leukemia after a bone marrow transplant
This early-phase trial tests an immune “T cell” therapy made to recognize a specific leukemia target. It is for people whose acute leukemia has come back (relapsed) or did not fully respond after receiving a donor stem cell transplant.
Seattle, WashingtonAges Up to 80 years
Hear when a new Recurrent Childhood Acute Myeloid Leukemia trial opens near Seattle, WA
We’ll email you when one opens near Seattle, WA — at most once a week, no account needed, unsubscribe anytime.
Where these studies are running near Seattle
Institutions with a site for the recruiting recurrent childhood acute myeloid leukemia studies listed above.
- Fred Hutchinson Cancer Center · 2 studies
- Seattle Children's Hospital
What taking part in a recurrent childhood acute myeloid leukemia study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting recurrent childhood acute myeloid leukemia studies in Washington.
Common questions
- Are there recurrent childhood acute myeloid leukemia clinical trials near Seattle?
- Yes. We're currently tracking 3 recruiting recurrent childhood acute myeloid leukemia studies with a site near Seattle, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a recurrent childhood acute myeloid leukemia study near Seattle?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Seattle to take part?
- Not necessarily. These studies have a site near Seattle, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a recurrent childhood acute myeloid leukemia trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New recurrent childhood acute myeloid leukemia studies open near Seattle regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.